中國東方航空股份(00670.HK):東航海外(香港)發行3000億韓元債券
格隆匯12月6日丨中國東方航空股份(00670.HK)公告,2019年10月,中國東方航空股份有限公司收到國家發展改革委員會的《企業借用外債備案登記證明》(發改辦外資備[2019]771號),對公司香港全資子公司東航海外(香港)有限公司(“發行人”)擬在境外發行不超過3000億元韓元債券(約摺合2.6億美元)予以登記,有效期至2020年10月止。2019年12月3日,發行人與KB證券株式會社(KBSecuritiesCo.,Ltd)簽訂承銷協議,發行於2022年到期、年利率為2.40%、3000億元韓元的阿里郎債券,並且債券獲得AA-評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.